Demirkan Gursel

1.5k total citations
32 papers, 970 citations indexed

About

Demirkan Gursel is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Demirkan Gursel has authored 32 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Genetics. Recurrent topics in Demirkan Gursel's work include Glioma Diagnosis and Treatment (10 papers), Cancer Cells and Metastasis (7 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Demirkan Gursel is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Cancer Cells and Metastasis (7 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Demirkan Gursel collaborates with scholars based in United States, China and Nigeria. Demirkan Gursel's co-authors include John A. Boockvar, David W. Infanger, Claudia Fischbach, Sunish Mohanan, Patrick Auguste, Pedro Cuevas, Diana Reimers, James P. Di Santo, Andréas Bikfalvi and Paul M. Lieberman and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Demirkan Gursel

31 papers receiving 957 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Demirkan Gursel United States 19 491 284 270 243 125 32 970
Saket Jain United States 18 455 0.9× 271 1.0× 256 0.9× 201 0.8× 67 0.5× 30 925
Daisuke Kita Japan 18 459 0.9× 248 0.9× 159 0.6× 340 1.4× 121 1.0× 53 1.1k
Chlöe Milsom Canada 21 664 1.4× 353 1.2× 310 1.1× 158 0.7× 47 0.4× 30 1.3k
Aizhen Xiao United States 15 393 0.8× 253 0.9× 189 0.7× 170 0.7× 61 0.5× 21 773
A. J. A. Terzis Germany 13 547 1.1× 244 0.9× 379 1.4× 181 0.7× 102 0.8× 16 1.0k
Kathy Astrahantseff Germany 17 645 1.3× 383 1.3× 308 1.1× 120 0.5× 46 0.4× 36 1.2k
K. Jason South Korea 17 354 0.7× 226 0.8× 249 0.9× 192 0.8× 53 0.4× 48 814
Markus Bredel United States 15 565 1.2× 199 0.7× 251 0.9× 276 1.1× 43 0.3× 28 914
Dirk Kemming Germany 15 683 1.4× 504 1.8× 423 1.6× 312 1.3× 59 0.5× 22 1.3k
Matilda Rehn Sweden 12 382 0.8× 292 1.0× 179 0.7× 112 0.5× 85 0.7× 24 862

Countries citing papers authored by Demirkan Gursel

Since Specialization
Citations

This map shows the geographic impact of Demirkan Gursel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Demirkan Gursel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Demirkan Gursel more than expected).

Fields of papers citing papers by Demirkan Gursel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Demirkan Gursel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Demirkan Gursel. The network helps show where Demirkan Gursel may publish in the future.

Co-authorship network of co-authors of Demirkan Gursel

This figure shows the co-authorship network connecting the top 25 collaborators of Demirkan Gursel. A scholar is included among the top collaborators of Demirkan Gursel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Demirkan Gursel. Demirkan Gursel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kitata, Reta Birhanu, Marija Veličković, Zhangyang Xu, et al.. (2025). Robust collection and processing for label-free single voxel proteomics. Nature Communications. 16(1). 547–547. 3 indexed citations
2.
Wang, Jun, Godwin Imade, Sulaimon Akanmu, et al.. (2024). Analytic performance of ScreenFire HPV RS assay Zebra BioDome format and its potential for large-scale population HPV screening. Infectious Agents and Cancer. 19(1). 59–59. 1 indexed citations
3.
Kumthekar, Priya, Sean Grimm, Marc C. Chamberlain, et al.. (2022). A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma. Neuro-Oncology Advances. 4(1). vdac123–vdac123. 20 indexed citations
4.
Musa, Jonah, Kyeezu Kim, Yinan Zheng, et al.. (2021). Accelerated epigenetic age among HIV-infected Nigerian women with invasive cervical cancer.. Journal of Clinical Oncology. 39(15_suppl). e17504–e17504. 1 indexed citations
5.
Poropatich, Kate, Tatjana Paunesku, Brian Wray, et al.. (2019). Elemental Zn and its Binding Protein Zinc-α2-Glycoprotein are Elevated in HPV-Positive Oropharyngeal Squamous Cell Carcinoma. Scientific Reports. 9(1). 16965–16965. 11 indexed citations
6.
Maniar, Kruti P., Beatriz Sánchez‐Sendra, Ajit Paintal, Demirkan Gursel, & Ritu Nayar. (2015). Role of the Biomarker p16 in Downgrading -IN 2 Diagnoses and Predicting Higher-grade Lesions. The American Journal of Surgical Pathology. 39(12). 1708–1718. 25 indexed citations
7.
Bondarenko, Gennadiy, Andrey Ugolkov, Stephen Rohan, et al.. (2015). Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors. Neoplasia. 17(9). 735–741. 65 indexed citations
8.
Gursel, Demirkan, Matei A. Banu, Roberta Marongiu, et al.. (2014). Tight regulation between cell survival and programmed cell death in GBM stem-like cells by EGFR/GSK3b/PP2A signaling. Journal of Neuro-Oncology. 121(1). 19–29. 26 indexed citations
9.
Infanger, David W., et al.. (2013). Glioblastoma Stem Cells Are Regulated by Interleukin-8 Signaling in a Tumoral Perivascular Niche. Cancer Research. 73(23). 7079–7089. 154 indexed citations
10.
Gursel, Demirkan, Cody D. Schlaff, & John A. Boockvar. (2012). EGFR Targeted Inhibition Resistance. Neurosurgery. 71(4). N17–N18. 1 indexed citations
11.
Hofstetter, Christoph P., Benjamin J. Shin, Demirkan Gursel, et al.. (2012). Protein Phosphatase 2A Mediates Dormancy of Glioblastoma Multiforme-Derived Tumor Stem-Like Cells during Hypoxia. PLoS ONE. 7(1). e30059–e30059. 56 indexed citations
12.
Stessin, A., Demirkan Gursel, Bhupesh Parashar, et al.. (2012). FTY720, sphingosine 1-phosphate receptor modulator, selectively radioprotects hippocampal neural stem cells. Neuroscience Letters. 516(2). 253–258. 29 indexed citations
13.
Santillán, Alejandro, Christoph P. Hofstetter, Paul J. Christos, et al.. (2012). Intra-arterial bevacizumab with blood brain barrier disruption in a glioblastoma xenograft model.. PubMed. 10(1). 31–7. 7 indexed citations
14.
15.
Gursel, Demirkan, Benjamin J. Shin, Jan‐Karl Burkhardt, et al.. (2011). Glioblastoma Stem-Like Cells—Biology and Therapeutic Implications. Cancers. 3(2). 2655–2666. 34 indexed citations
16.
Gursel, Demirkan, et al.. (2011). Direct Conversion of Human Fibroblasts to Functional Neurons in One Step. Neurosurgery. 69(6). N18–N19. 8 indexed citations
17.
Gursel, Demirkan, Robert G. Tuskan, Theonie Anastassiadis, et al.. (2011). Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapies. Neuro-Oncology. 13(6). 610–621. 38 indexed citations
18.
Gursel, Demirkan, Robel Beyene, Christoph P. Hofstetter, et al.. (2011). Optimization of glioblastoma multiforme stem cell isolation, transfection, and transduction. Journal of Neuro-Oncology. 104(2). 509–522. 17 indexed citations
19.
Turbyville, Thomas J., Demirkan Gursel, Robert G. Tuskan, et al.. (2010). Schweinfurthin A Selectively Inhibits Proliferation and Rho Signaling in Glioma and Neurofibromatosis Type 1 Tumor Cells in a NF1-GRD–Dependent Manner. Molecular Cancer Therapeutics. 9(5). 1234–1243. 29 indexed citations
20.
Gursel, Demirkan & Karlyne M. Reilly. (2005). Models of astrocytoma. Drug Discovery Today Disease Models. 2(1). 77–83.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saket Jain Breakdown of academic impact, for papers by Daisuke Kita Breakdown of academic impact, for papers by Chlöe Milsom Breakdown of academic impact, for papers by Aizhen Xiao Breakdown of academic impact, for papers by A. J. A. Terzis Breakdown of academic impact, for papers by Kathy Astrahantseff Breakdown of academic impact, for papers by K. Jason Breakdown of academic impact, for papers by Markus Bredel Breakdown of academic impact, for papers by Dirk Kemming Breakdown of academic impact, for papers by Matilda Rehn
Rankless by CCL
2026